Oct 31, 2018 7:30am EDT ProMIS Neurosciences Identifies Novel Targets on Tau Protein Involved in the Development of Alzheimer's Disease and Other Dementias
Oct 11, 2018 7:30am EDT ProMIS Neurosciences Identifies Novel Antibody Drug Candidates for Parkinson's Disease
Sep 17, 2018 7:30am EDT ProMIS Neurosciences to Present at Extraordinary Futures Investment Conference
Aug 21, 2018 7:30am EDT ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Aug 07, 2018 7:30am EDT ProMIS Neurosciences Issues Narrated Commentary on Key Learnings from AAIC 2018
Jul 31, 2018 7:30am EDT ProMIS Neurosciences Issues White Paper Entitled 'State of the Art at AAIC 2018'